Product

MDI-1228

Aliases

MDI-1228_mesylate Ophthalmic Solution

1 clinical trial

1 indication

Indication

Allergic Conjunctivitis

Clinical trial

A Phase 1, First-in-Human, Single-center, Randomized, Double-masked, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of MDI-1228_mesylate Ophthalmic Solution by Local Instillation in Adult Healthy Volunteers

Status: Recruiting, Estimated PCD: 2024-07-01